申请人:PFIZER INC.
公开号:EP0397364A1
公开(公告)日:1990-11-14
Heterocyclicguanidines as 5HT₃ antagonists useful in the treatment of nausea, anxiety, pain, schizophrenia and gastrointestinal disorders, of the formula
and their pharmaceutically acceptable acid addition salts, wherein Ar is naphthyl, indol-3-yl, 2-methyl-indol-3-yl, 1-methylindol-3-yl, 1-benzylindol-3-yl, phenyl, or mono- or disubstituted phenyl wherein said substituent is each methyl, methoxy, chloro, fluoro or bromo; Het is thiazolyl, furyl, thienyl or isoxazolyl, R₁ is hydrogen or methyl; R₂ and R₃ when considered separately are each hydrogen, hydroxyethyl, alkyl having one to six carbon atoms, cycloalkyl having three to six carbon atoms or acetyl; and R₂ and R₃ when taken together are alkylene having two to three carbon atoms.
作为 5HT₃ 拮抗剂,可用于治疗恶心、焦虑、疼痛、精神分裂症和胃肠道疾病的杂环胍类化合物,其式为
及其药学上可接受的酸加成盐,其中 Ar 为萘基、吲哚-3-基、2-甲基吲哚-3-基、1-甲基吲哚-3-基、1-苄基吲哚-3-基、苯基或单取代或二取代苯基,其中所述取代基分别为甲基、甲氧基、氯代、氟代或溴代;Het 是噻唑基、呋喃基、噻吩基或异噁唑基,R₁ 是氢或甲基;R₂ 和 R₃ 分开看分别是氢、羟乙基、具有 1 至 6 个碳原子的烷基、具有 3 至 6 个碳原子的环烷基或乙酰基;R₂ 和 R₃ 合在一起看是具有 2 至 3 个碳原子的亚烷基。